Methylene Blue vs Cyanokit for Intraoperative Vasoplegic Syndrome in Liver Transplant Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2019

Primary Completion Date

February 27, 2023

Study Completion Date

February 27, 2024

Conditions

Vasoplegic SyndromeLiver Transplant; Complications

Interventions

DRUG

Hydroxocobalamin

Hydroxocobalamin (Cyanokit): 5g IV infusion over 15 minutes

DRUG

Methylene Blue

Methylene blue (PROVAYBLUETM), 2 mg/kg IV bolus administered over 15 minutes

Trial Locations (1)

Mayo Clinic in Florida, Jacksonville